ARKG

ARK Genomic Revolution ETF is a collection of stocks from companies working on cutting-edge genetic and medical technologies. It allows regular investors to buy one fund that gives them exposure to dozens of companies in DNA sequencing, gene editing, molecular diagnostics, and biotechnology. The fund makes money by charging a small percentage fee based on how much money investors have put into it, which covers management costs and operations.